Answers are grounded in this paper and cite their sources.
Review reveals emerging preventive trials in susceptible populations, highlighting immune tolerance and dietary interventions to halt diabetes.
Recent advances in the understanding of the pathogenesis of insulin-dependent diabetes mellitus (IDDM) have led to the first trials of disease prevention in susceptible individuals. Two main trials (nicotinamide and insulin) are now running but first results will not be available before the turn of the century. Pilot trials using different approaches, most of them based on the induction of immunotolerance, are also under way and should offer new insight for establishing larger multicentre studies including attempts aimed at primary prevention by removal of diabetogenic components in cow's milk. The field is moving fast and it is expected that intervention for IDDM prevention will be offered to an increasing number of individuals found at risk of developing the disease.
No takes yet. Share an insight, caveat, or question.
Paolo Pozzilli (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: